Albumedix Ltd. (‘Albumedix’), a recognized global leader in recombinant human albumin specializing in the enablement of advanced therapies, announces the […]
Scientists launch clinical trial of CRISPR gene correction therapy in patients with sickle cell disease
Scientists at UC San Francisco, UC Berkeley and UCLA have received U.S. Food and Drug Administration approval to jointly launch […]